Dexcom sees revenue growth in Q2 2020 despite COVID-19 uncertainties
Mobi Health News
JULY 31, 2020
Dexcom president and CEO Kevin Sayer is “incredibly proud” of what the company is calling “resilient growth” in the second quarter of 2020, according to an earnings call on Tuesday. Despite having some uncertainty in the impacts of the COVID-19 pandemic, Dexcom was able to produce significant year-over-year growth in Q2 2020. Sayer attributes much of the growth to a steady increase in knowledge of the company’s continuous glucose monitor (CGM), the Dexcom G6, among patients.
Let's personalize your content